IR
71
-4
PPL
57
10
PCAR
64
5
CL
50
3
UPS
45
-3
LB
82
19
VTR
50
3
CA
22
12
M
36
-6
EW
27
2
CRM
67
2
SYY
49
2
HRB
59
-7
PX
73
4
DD
60
-7
MHK
52
2
HBI
59
-6
SE
50
-5
OKE
80
2
NKE
30
2
IR
71
-4
PPL
57
10
PCAR
64
5
CL
50
3
UPS
45
-3
LB
82
19
VTR
50
3
CA
22
12
M
36
-6
EW
27
2
CRM
67
2
SYY
49
2
HRB
59
-7
PX
73
4
DD
60
-7
MHK
52
2
HBI
59
-6
SE
50
-5
OKE
80
2
NKE
30
2
Financhill
Back

Predictive Oncology Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
47

POAI
Predictive Oncology

Last Price:
0.75
Seasonality Move:
4.2%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Predictive Oncology Price Quote

$0.75
+0.01 (+-9.42%)
(Updated: November 9, 2024 at 5:42 AM ET)

Predictive Oncology Key Stats

Sell
47
Predictive Oncology (POAI) is a Sell
Day range:
$0.74 - $0.85
52-week range:
$0.55 - $3.76
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.78
P/B ratio:
1.21%
Volume:
142.5K
Avg. volume:
115K
1-year change:
-77.23%
Market cap:
$4.9M
Revenue:
$1.8M
EPS:
$-3.35

How Much Does Predictive Oncology Make?

Is Predictive Oncology Growing As A Company?

  • What Is Predictive Oncology's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.43%
  • What Is Predictive Oncology's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Predictive Oncology Stock Price Performance

What Is Predictive Oncology 52-Week High & Low?

Predictive Oncology Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Predictive Oncology?

Is Predictive Oncology Cash Flow Positive?

  • What Is POAI Cash Flow From Operations?
    Cash flow from operations (TTM) is -$12.8M
  • What Is Predictive Oncology’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $3.4M
  • What Is Predictive Oncology’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6.1K

Predictive Oncology Return On Invested Capital

  • Is Management Doing A Good Job?
    POAI return on invested capital is -161.36%
  • What Is Predictive Oncology Return On Assets?
    ROA measures how assets are converting to revenues and is -93.92%
  • What Is POAI Return On Equity?
    ROE is a measure of profitability and is -164.1%

Predictive Oncology Earnings Date & Stock Price

Predictive Oncology Competitors

  • Who Are Predictive Oncology's Competitors?
    Below is a list of companies who compete with Predictive Oncology or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • InfuSystems Holdings Inc (INFU)
    • Retractable Technologies Inc (RVP)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

Predictive Oncology Dividend Yield

Predictive Oncology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -43.13% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 3.00
Upside from Last Price: 305.35%

Major Shareholders

  • How many POAI shares are owned by institutional investors?
    359.1K POAI shares are owned by institutional investors
  • How many POAI shares are owned by insiders?
    5.8M POAI shares are owned by insiders